Leading Global Sports Medicine Companies in 2025
16 May, 2025

The sports medicine market is anticipated to grow at a compound annual growth rate (CAGR) of 6.04% from 2025 to 2033, from US$ 7.27 billion in 2024 to US$ 12.32 billion by 2033. Similarly, the North America sports medicine market is anticipated to grow at a compound annual growth rate (CAGR) of 5.81% from 2025 to 2033, from US$ 2.50 billion in 2024 to US$ 4.15 billion by 2033. Growing awareness of preventative care, increased engagement in sports and fitness activities, and technological breakthroughs in medicine are all contributing to the notable rise of the worldwide sports medicine market. Body support and rehabilitation, body rebuilding and repair, and accessories are important sections. Due to its established healthcare system and strong demand for sports-related medical services, North America now commands the greatest market share. With a sizable youth population, better healthcare infrastructure, and growing interest in sports and fitness, the Asia Pacific area is expected to develop at the quickest rate. In the upcoming years, the market is anticipated to grow even more due to factors such government programs encouraging physical activity, technology advancements, and a trend towards preventative treatment.

Sports medicine companies concentrate on creating cutting-edge solutions for rehabilitation, treatment, and injury prevention. In order to improve athlete recovery, performance, and long-term musculoskeletal health, they invest in innovation and develop alliances with sports organizations. Their products range from orthopedic implants to physiotherapy equipment.

Discover key trends, growth opportunities, and major challenges shaping the Sports Medicine Industry in Renub Research’s latest in-depth market report. Download your free sample now

Top Sports Injury Recovery Product Companies

Zimmer Biomet Holdings, Inc.

Establishment: 1927

Headquarters: United States of America

Website: www.zimmerbiomet.com/en

Revenue: $7.7B in 2023

The medical device business Zimmer Biomet Holdings Inc. (Zimmer Biomet) specializes in musculoskeletal treatment. Biologics, sports medicine, trauma, extremities, and orthopedic reconstructive products are all designed, produced, and marketed by the company. It also produces a suite of integrated digital and robotic technologies, office-based technologies, craniomaxillofacial and thoracic products, and related surgical products. Patients with diseases or injuries of the bones, joints, and supporting soft tissues can benefit from its products and remedies. In addition to hospitals, healthcare dealers, healthcare buying organizations, orthopedic surgeons, neurosurgeons, and other experts, Zimmer Biomet also supplies stocking distributors. Direct sales channels and distributors across the Americas, Europe, Asia-Pacific, the Middle East, and Africa are how the corporation advertises its goods. The US headquarters of Zimmer Biomet are located in Warsaw, Indiana.

Medtronic Plc.

Establishment: 1949

Headquarters: Ireland

Website: www.medtronic.com

Revenue: $32.4B in 2023

The medical technology business Medtronic plc (Medtronic) creates, develops, produces, and sells medical equipment and solutions. Research, design, production, and sales of biomedical engineering products are among the company's primary endeavors. It provides products to treat heart valve problems, heart failure, aortic, peripheral vascular, venous, renal, and neurological illnesses, as well as disorders of the spine, musculoskeletal system, and the ears, nose, and throat. Additionally, Medtronic offers biologic solutions for the dentistry and orthopedic industries. In Asia Pacific, Europe, the Americas, the Middle East, and Africa, the firm sells its goods to hospitals, clinics, third-party healthcare providers, government healthcare programs, distributors, and group purchasing groups. The headquarters of Medtronic are located in Dublin, Ireland.

Smith & Nephew Plc.

Establishment: 1856

Headquarters: United Kingdom

Website: www.cinfin.com

Revenue: $5.8B in 2023

Smith & Nephew Plc (Smith & Nephew) is a medical technology firm that creates, produces, and sells medical devices for advanced wound care, sports medicine, orthopedic reconstruction and trauma, and ENT. Advanced goods and tools for repairing or removing soft tissue, hip, knee, and shoulder replacement systems, robotics-assisted and digital enabling solutions, wound dressings, advanced wound bio-actives, and advanced wound devices are among its offerings. Under the trademarks Oasis, Opsite, Pico, Primapore, Profore, and Renasys, among others, the firm sells its products to surgeons, nurses and nurse specialists, doctors and general practitioners, and purchasing professionals in hospitals and healthcare insurers. The firm sells its goods across the Middle East, Africa, Asia Pacific, Europe, and the Americas. In the United Kingdom, Smith & Nephew's headquarters are located in Watford, Hertfordshire.

Stryker

Establishment: 1941

Headquarters: United States of America

Website: www.stryker.com

Revenue: $22.6B in 2023

Stryker Corp. (Stryker) is a medical technology firm that manufactures spine, neurotechnology, orthopedic, and medical and surgical equipment. Orthopedic implants, surgical equipment and surgical navigation systems, endoscopic and communications systems, patient management, emergency medical equipment, and disposables for critical care are some of its main items. Additionally, it provides spinal, neurovascular, and neurosurgical equipment as well as medical gadgets for a range of ailments. Physicians, hospitals, and other healthcare organizations can purchase Stryker's goods. In the Americas, Europe, Asia-Pacific, the Middle East, and Africa, the corporation offers its goods through subsidiaries, branches, independent dealers, and distributors. The US city of Portage, Michigan, is home to Stryker's headquarters.

Novartis AG

Establishment: 1996

Headquarters: Switzerland

Website: www.novartis.com

Revenue: $51.7B in 2023

The pharmaceutical business Novartis AG (Novartis) is involved in the discovery, production, marketing, distribution, and distribution of novel medications. In therapeutic domains including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neurology, and cancer, it provides a variety of products. Through brands like Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, the company distributes its products to pharmacies, private health systems, government agencies, doctors, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems worldwide. It runs production plants in China, France, Italy, Switzerland, Austria, Slovenia, and the United States. The headquarters of Novartis are located in Basel, Switzerland.

Johnson & Johnson Services, Inc.

Establishment: 1979

Headquarters: United States of America

Website: www.jnj.com

Revenue: $88.8B in 2023

Research, development, production, and distribution of cutting-edge medications and medical technology are the activities of Johnson & Johnson (J&J), a healthcare organization. The corporation uses its operational companies to carry out its activities. It offers medical equipment for use in the sectors of cardiovascular, orthopedic, neurovascular, general surgery, and vision care, as well as pharmaceutical items for treatment areas linked to immunological disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic illnesses. The business sells its goods to hospitals, wholesalers, medical experts, and retailers. It has production facilities across the Western Hemisphere (apart from the US), Africa, Asia-Pacific, Europe, Latin America, and the United States. The US city of New Brunswick, New Jersey, is home to J&J's headquarters.

ConMed Corporation

Establishment: 1970

Headquarters: United States of America

Website: www.conmed.com

Revenue: $1.3B in 2024

The medical technology business ConMed Corp (ConMed) produces and markets surgical equipment and technologies for monitoring and minimally invasive operations. Reconstructive systems, bronchoscopy devices, endoscopic ligator kits, stone removal balloons, trocars, graspers, scissors, suction irrigation devices, electrosurgical generators, smoke evacuation pencils, pencil sheaths, saws, blades, endo mechanical instrumentation, and surgical visualization equipment are among the company's main products. ConMed serves the markets for sports medicine, pulmonology, gastrointestinal, gynecology, orthopedics, general surgery, and anesthesiology. The business uses medical specialty wholesalers and a direct sales staff to offer its goods. It has operations throughout Asia-Pacific, Europe, the Middle East, and the Americas. The US state of Florida is home to ConMed's headquarters.

Surgalign Holdings.

Establishment: 1997

Headquarters: United States of America

Website: www.surgalign.com

Revenue: $82.0M in 2022

The medical technology business Surgalign Holdings Inc. (Surgalign), formerly known as RTI Surgical Inc., creates, produces, sells, and distributes biomaterials and spinal metal implants. For common spine fusion procedures like anterior cervical ciscectomy and fusion (ACDF) and posterior cervical fusion (PCF), Spine Implants provides a variety of cervical, thoracic, and lumbar interbody devices, including Fortilink cages with TETRAfuse and TiPlusTM technologies and supplemental fixation devices like Streamline MIS or Degen or OCT pedicle screws and CervAlign ACDF plating system devices. From advanced tissue-based treatments to complex synthetic bone graft substitutes, the biomaterials are used in surgical procedures. The US state of Illinois is home to Surgalign's headquarters.